Patent ID: 7041785

Claim:
A method of treating a B 1 -bradykinin receptor mediated inflammatory condition in a mammal, said method comprising the step of administering to said mammal a therapeutically effective amount of a B 1 -bradykinin receptor antagonist of the Formula I: A-Arg-Pro-B-Gly-Phe-Ser-C-E (Formula I, SEQ ID NO: 47 or SEQ ID NO: 48), wherein the groups A, B, C and E are independently defined and with the proviso that said B 1 -bradykinin receptor antagonist is not SEQ ID NO: 15 or SEQ ID NO: 16, wherein said B 1 -bradykinin receptor antagonist is administered under conditions effective to ameliorate the B 1 -bradykinin receptor mediated inflammatory condition in said mammal.